Mainstream

Kuros Bioscience GAAP EPS of -$0.05, revenue of $63.48M misses by $19.35M; reaffirms FY outlook

Kuros Bioscience GAAP EPS of -$0.05, revenue of $63.48M misses by $19.35M; reaffirms FY outlook

Post ContentcsbtfRead More

You might also be interested in reading Bitstamp apologizes after posting report calling XRP ‘toxic waste’.

August 14, 2025
In Mainstream